BAP1 and mesothelioma: Consistent with these results, by accounting for copy number loss and long indels, The Cancer Genome Atlas (TCGA) demonstrated an increase of 40% of alterations over single-nucleotide variants alone, leading to decreased BAP1 expression among patients with mesothelioma represented in the TCGA dataset (25).